MedTrace Logo

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

NCT07533786 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-04-21

No results posted yet for this study

Summary

This is a multi-center, randomized, double-blind, double-dummy, placebo/active-controlled study. 200 subjects undergoing abdominal surgery under general anesthesia are planned to be enrolled and randomized into the HSK55718 group, morphine group, and placebo group.

Conditions

  • Pain After Surgery

Interventions

DRUG

HSK55718 dose level1

Patients administrated with HSK55718 at dose level 1

DRUG

HSK55718 dose level2

Patients administrated with HSK55718 at dose level 2

DRUG

HSK55718 dose level 3

Patients administrated with HSK55718 at dose level 3

DRUG

Placebo control

Patients administrated with placebo

DRUG

morphine

Patients administrated with morphine

Sponsors & Collaborators

  • Haisco Pharmaceutical Group Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2027-04-20
Completion
2027-04-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07533786 on ClinicalTrials.gov